SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-03-074419
Filing Date
2003-11-06
Accepted
2003-11-06 16:44:45
Documents
4
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q FOR THE THIRD QUARTER d10q.htm 10-Q 361607
3 CERTIFICATION OF CEO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT dex311.htm EX-31.1 8609
4 CERTIFICATION OF CFO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT dex312.htm EX-31.2 8608
5 CERTIFICATION OF PERIODIC FINANCIAL REPORT BY THE CEO & CFO dex32.htm EX-32 5409
  Complete submission text file 0001193125-03-074419.txt   386139
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23272 | Film No.: 03982741
SIC: 2836 Biological Products, (No Diagnostic Substances)